Evaluating women's acceptability of treatment of incomplete second trimester abortion using misoprostol provided by midwives compared with physicians: a mixed methods study

Susan Atuhairwe, Claudia Hanson, Lynn Atuyambe, Josaphat Byamugisha, Nazarius Mbona Tumwesigye, Ronald Ssenyonga, Kristina Gemzell-Danielsson, Susan Atuhairwe, Claudia Hanson, Lynn Atuyambe, Josaphat Byamugisha, Nazarius Mbona Tumwesigye, Ronald Ssenyonga, Kristina Gemzell-Danielsson

Abstract

Background: Studies evaluating task sharing in postabortion care have mainly focused on women in first trimester and many lack a qualitative component. We aimed to evaluate patient acceptability of treatment of incomplete second trimester abortion using misoprostol provided by midwives compared with physicians and also gained a deeper understanding of the patients' lived treatment experiences in Uganda.

Methods: Our mixed methods study combined 1140 structured interview data from a randomized controlled equivalence trial and in-depth interviews (n = 28) among women managed with misoprostol for second trimester incomplete abortion at 14 public health facilities in Uganda. Acceptability, our main outcome, was measured at the 14-day follow-up visit using a structured questionnaire as a composite variable of: 1) treatment experience (as expected/ better than expected/ worse than expected), and 2) satisfaction - if patient would recommend the treatment to a friend or choose the method again. We used generalized mixed effects models to obtain the risk difference in acceptable post abortion care between midwife and physician groups. We used inductive content analysis for qualitative data.

Results: From 14th August 2018 to 16th November 2021, we assessed 7190 women for eligibility and randomized 1191 (593 to midwife and 598 to physician). We successfully followed up 1140 women and 1071 (94%) found the treatment acceptable. The adjusted risk difference was 1.2% (95% CI, - 1.2 to 3.6%) between the two groups, and within our predefined equivalence range of - 5 to + 5%. Treatment success and feeling calm and safe after treatment enhanced acceptability while experience of side effects and worrying bleeding patterns reduced satisfaction.

Conclusions: Misoprostol treatment of uncomplicated second trimester incomplete abortion was equally and highly acceptable to women when care was provided by midwives compared with physicians. In settings that lack adequate staffing levels of physicians or where midwives are available to provide misoprostol, task sharing second trimester medical PAC with midwives increases patient's access to postabortion care services.

Trial registration: ClinicalTrials.gov NCT03622073.

Keywords: Acceptability; Incomplete abortion; Misoprostol; Post abortion care; Second trimester; Task sharing; Uganda.

Conflict of interest statement

None to declare.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Trial profile

References

    1. Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–e333. doi: 10.1016/S2214-109X(14)70227-X.
    1. Faundes A, Comendant R, Dilbaz B, Jaldesa G, Leke R, Mukherjee B, et al. Preventing unsafe abortion: achievements and challenges of a global FIGO initiative. Best Pract Res Clin Obstet Gynaecol. 2020;62:101–112. doi: 10.1016/j.bpobgyn.2019.05.016.
    1. World Health Organization . Safe abortion: technical and policy guidance for health systems. 2. Geneva: Switzerland; 2012.
    1. Ngalame A, Tchounzou R, Neng H, Mangala F, Inna R, Kamdem D, Moustapha B, Dohbit J, Kongnyuy E, Noa C, Lenka B, Halle G, Mwadjie D, Delvaux T, Mboudou E. Improving post abortion care (PAC) delivery in sub-Saharan Africa: a literature review. Open J Obstet Gynecol. 2020;10:1295–1306. doi: 10.4236/ojog.2020.1090119.
    1. Atuhairwe S, Gemzell-Danielsson K, Byamugisha J, Kaharuza F, Tumwesigye NM, Hanson C. Abortion-related near-miss morbidity and mortality in 43 health facilities with differences in readiness to provide abortion care in Uganda. BMJ Glob Health. 2021;6(2):e003274. doi: 10.1136/bmjgh-2020-003274.
    1. Atuhairwe S, Byamugisha J, Kakaire O, Hanson C, Cleeve A, Klingberg-Allvin M, et al. Comparison of the effectiveness and safety of treatment of incomplete second trimester abortion with misoprostol provided by midwives and physicians: a randomised, controlled, equivalence trial in Uganda. Lancet Glob Health. 2022;10(10):e1505–e13.
    1. Cleeve A, Byamugisha J, Gemzell-Danielsson K, Mbona Tumwesigye N, Atuhairwe S, Faxelid E, et al. Women’s acceptability of misoprostol treatment for incomplete abortion by midwives and physicians - secondary outcome analysis from a randomized controlled equivalence trial at district level in Uganda. PLoS One. 2016;11(2):e0149172. doi: 10.1371/journal.pone.0149172.
    1. Kopp Kallner H, Gomperts R, Salomonsson E, Johansson M, Marions L, Gemzell-Danielsson K. The efficacy, safety and acceptability of medical termination of pregnancy provided by standard care by doctors or by nurse-midwives: a randomised controlled equivalence trial. BJOG. 2015;122(4):510–517. doi: 10.1111/1471-0528.12982.
    1. Neilson JP, Gyte GM, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2013;(3):CD007223.
    1. Winikoff B, Sivin I, Coyaji KJ, Cabezas E, Xiao B, Gu S, et al. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. Am J Obstet Gynecol. 1997;176(2):431–437. doi: 10.1016/S0002-9378(97)70511-8.
    1. Dah T, Akiode A, Awah P, Fetters T, Okoh M, Ujah I, et al. Introducing misoprostol for the treatment of incomplete abortion in Nigeria. Afr J Reprod Health. 2011;15(4):42–50.
    1. Ngoc NT, Shochet T, Blum J, Hai PT, Dung DL, Nhan TT, et al. Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals: implications for task shifting. BMC Pregnancy Childbirth. 2013;13:118. doi: 10.1186/1471-2393-13-118.
    1. Spillane JP, Pareja AS, Dorner L, Barnes C, May H, Huff J, Camburn E. Mixing methods in randomized controlled trials (RCTs): validation, contextualization, triangulation, and control. Educ Assess Eval Account. 2010;22(1):5–28. doi: 10.1007/s11092-009-9089-8.
    1. Creswell JW. Research design: qualitative and mixed methods approaches. London: SAGE; 2009.
    1. Grissmer DW. A guide to incorporating multiple methods in randomized control trials to assess intervention effects. 2 2016.
    1. Prada E, Atuyambe LM, Blades NM, Bukenya JN, Orach CG, Bankole A. Incidence of induced abortion in Uganda, 2013: new estimates since 2003. PLoS One. 2016;11(11):e0165812. doi: 10.1371/journal.pone.0165812.
    1. Government of Uganda, Ministry of Health: The National Annual Maternal and Perinatal Death Surveillance and Response (MPDSR) Report FY 2019/2020.
    1. Ministry of Health, Uganda. National Policy Guidelines for Sexual Reproductive Health Services, C.H.D. Reproductive Health Division, Editor. 2011, Reproductive Health Division, Community Health Department Kampala.
    1. Niinimäki M, Mentula M, Jahangiri R, Männistö J, Haverinen A, Heikinheimo O. Medical treatment of second-trimester fetal miscarriage; a retrospective analysis. PLoS One. 2017;12(7):e0182198. doi: 10.1371/journal.pone.0182198.
    1. Mark AG, Edelman A, Borgatta L. Second-trimester postabortion care for ruptured membranes, fetal demise, and incomplete abortion. Int J Gynaecol Obstet. 2015;129(2):98–103. doi: 10.1016/j.ijgo.2014.11.011.
    1. WHO. Abortion care guideline. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
    1. Atuhairwe S, Byamugisha J, Klingberg-Allvin M, Cleeve A, Hanson C, Tumwesigye NM, et al. Evaluating the safety, effectiveness and acceptability of treatment of incomplete second-trimester abortion using misoprostol provided by midwives compared with physicians: study protocol for a randomized controlled equivalence trial. Trials. 2019;20(1):376. doi: 10.1186/s13063-019-3490-5.
    1. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. International J Qual Health Care. 2007;19(6):349–357. doi: 10.1093/intqhc/mzm042.
    1. Okonofua F, Shittu O, Shochet T, Diop A, Winikoff B. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria. Int J Gynaecol Obstet. 2014;125(1):49–52. doi: 10.1016/j.ijgo.2013.10.009.
    1. Paul M, Iyengar K, Essen B, Gemzell-Danielsson K, Iyengar SD, Bring J, et al. Acceptability of home-assessment post medical abortion and medical abortion in a low-resource setting in Rajasthan, India. Secondary outcome analysis of a non-inferiority randomized controlled trial. PLoS One. 2015;10(9):e0133354. doi: 10.1371/journal.pone.0133354.
    1. Makenzius M, Oguttu M, Klingberg-Allvin M, Gemzell-Danielsson K, Odero TMA, Faxelid E. Post-abortion care with misoprostol - equally effective, safe and accepted when administered by midwives compared to physicians: a randomised controlled equivalence trial in a low-resource setting in Kenya. BMJ Open. 2017;7(10):e016157. doi: 10.1136/bmjopen-2017-016157.
    1. Samnani AABA, Rizvi N, Ali TS, Abrejo F. Barriers or gaps in implementation of misoprostol use for post-abortion care and post-partum hemorrhage prevention in developing countries: a systematic review. Reprod Health. 2017;14(1):139. doi: 10.1186/s12978-017-0383-5.
    1. Paul M, Gemzell-Danielsson K, Kiggundu C, Namugenyi R, Klingberg-Allvin M. Barriers and facilitators in the provision of post-abortion care at district level in Central Uganda – a qualitative study focusing on task sharing between physicians and midwives. BMC Health Serv Res. 2014;14(1):28. doi: 10.1186/1472-6963-14-28.
    1. Aantjes CJ, Gilmoor A, Syurina EV, Crankshaw TL. The status of provision of post abortion care services for women and girls in eastern and southern Africa: a systematic review. Contraception. 2018;98(2):77–88. doi: 10.1016/j.contraception.2018.03.014.
    1. Onyegbule OA, Onumajuru CC, Ododo NA, Idih EE, Onyegbule PC. Uptake of post-abortion contraception among women who had manual vacuum aspiration at Federal Medical Centre, Owerri: a 5-year review. Trop J Obstet Gynaecol. 2016;33(2):228. doi: 10.4103/0189-5117.192234.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa